TY  - JOUR

T1  - Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial.

JO  - Journal of Clinical Oncology

PY  - 2013/05/20

AU  - Goss PE

AU  - Barrios CH

AU  - Chan A

AU  - Finkelstein DM

AU  - Iwata H

AU  - Martin M

AU  - Braun A

AU  - Ding B

AU  - Maniar T

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1200/jco.2013.31.15_suppl.tps662

PB  - American Society of Clinical Oncology (ASCO)

VL  - 31

IS  - 15_suppl

SP  - TPS662

EP  - TPS662

Y2  - 2025/10/10

ER  -